Lynne Marie Sullivan - 02 Apr 2025 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
CFO & Head of Corp. Dev.
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Lynne Sullivan
Issuer symbol
UBX
Transactions as of
02 Apr 2025
Net transactions value
-$22,523
Form type
4
Filing time
03 Apr 2025, 16:16:04 UTC
Previous filing
31 Mar 2025
Next filing
13 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Sale $22,523 -21,867 -18% $1.03 98,905 02 Apr 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.